Amgen Inc.: shareholders and insiders

AMGNNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$438.82

November 19, 2026Market cap $237B

What Ploutos Investor adds for Amgen

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Nov 9, 2026, from their own Form 4 filings.

11 Form 4s

Bought on the market

–

nobody

Sold on the market

$27M

5 people

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $26M by 5 people

  • 2025: no buys, sold $1.1M by 1 person
  • 2026: no buys, sold $26M by 5 people
  • Nov 6, 2026Omar IshrakDirector
    Kind
  • Nov 6, 2026Charles M HolleyDirector
    Kind
  • Nov 6, 2026David W GibbsDirector
    Kind
  • Nov 6, 2026Michael Drake VDirector
    Kind
  • Aug 13, 2026Rachna KhoslaSVP, Business Development
    Kind
  • Aug 13, 2026Rachna KhoslaSVP, Business Development
    Kind
  • Aug 11, 2026Rachna KhoslaSVP, Business Development
    Kind
  • Aug 7, 2026Matthew C. BuschVP, Finance & CAO
    Kind
  • Aug 7, 2026Omar IshrakDirector
    Kind
  • Aug 7, 2026Charles M HolleyDirector
    Kind
  • Aug 7, 2026Michael Drake VDirector
    Kind
  • Aug 6, 2026Derek MillerSVP, Human Resources
    Kind
  • Aug 6, 2026Derek MillerSVP, Human Resources
    Kind
  • Aug 6, 2026Derek MillerSVP, Human Resources
    Kind
  • Aug 6, 2026Derek MillerSVP, Human Resources
    Kind
  • Aug 6, 2026Nancy A. GrygielSVP & CCO
    Kind
  • Aug 6, 2026Nancy A. GrygielSVP & CCO
    Kind
  • Aug 6, 2026Nancy A. GrygielSVP & CCO
    Kind
  • Aug 6, 2026Nancy A. GrygielSVP & CCO
    Kind
  • May 4, 2026Nancy A. GrygielSVP & CCO
    Kind
  • Feb 26, 2026Esteban SantosEVP, Operations
    Kind
  • Feb 26, 2026Esteban SantosEVP, Operations
    Kind
  • Feb 19, 2026Matthew C. BuschVP, Finance & CAO
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Aug 7, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by AMGN's officers and directors from 2006 up to November 18, 2025, 20 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%May 14, 2026 Latest filing
  • BlackRock, Inc.
    Share of class7.60%
  • Vanguard Capital Management
    Share of class7.51%
  • Capital World Investors
    Share of class5.50%
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • The Vanguard Group0.00%Mar 26, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Jun 30, 2026 quarter end
  • D.E. Shaw
    In the quarter+625%
  • Citadel Advisors (Griffin)
    In the quarter+281%
  • AQR Capital
    In the quarter+97%
  • Bridgewater (Dalio)
    In the quarter+48%
  • Millennium Mgmt (Englander)
    In the quarter-66%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 2.48% of its shares outstanding were held short, -4.6% since the report before.

Shares held short
13.38M
2.48%
Since the report before14.03M on Sep 30, 2026
-4.6%
5.0
2.69M
More days to cover thanof 4,578 US-listed companies with enough volume
61%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 6.42M
  • Nov 15, 2023: Shares held short 6.77M
  • Nov 30, 2023: Shares held short 8.10M
  • Dec 15, 2023: Shares held short 9.06M
  • Dec 29, 2023: Shares held short 9.04M
  • Jan 12, 2024: Shares held short 8.84M
  • Jan 31, 2024: Shares held short 9.30M
  • Feb 15, 2024: Shares held short 11.09M
  • Feb 29, 2024: Shares held short 11.02M
  • Mar 15, 2024: Shares held short 11.11M
  • Mar 28, 2024: Shares held short 10.47M
  • Apr 15, 2024: Shares held short 10.11M
  • Apr 30, 2024: Shares held short 9.72M
  • May 15, 2024: Shares held short 10.25M
  • May 31, 2024: Shares held short 9.05M
  • Jun 14, 2024: Shares held short 9.12M
  • Jun 28, 2024: Shares held short 8.98M
  • Jul 15, 2024: Shares held short 9.58M
  • Jul 31, 2024: Shares held short 9.79M
  • Aug 15, 2024: Shares held short 9.24M
  • Aug 30, 2024: Shares held short 8.48M
  • Sep 13, 2024: Shares held short 9.00M
  • Sep 30, 2024: Shares held short 9.81M
  • Oct 15, 2024: Shares held short 9.37M
  • Oct 31, 2024: Shares held short 8.82M
  • Nov 15, 2024: Shares held short 9.81M
  • Nov 29, 2024: Shares held short 11.14M
  • Dec 13, 2024: Shares held short 11.53M
  • Dec 31, 2024: Shares held short 11.17M
  • Jan 15, 2025: Shares held short 11.43M
  • Jan 31, 2025: Shares held short 12.74M
  • Feb 14, 2025: Shares held short 16.08M
  • Feb 28, 2025: Shares held short 16.16M
  • Mar 14, 2025: Shares held short 15.06M
  • Mar 31, 2025: Shares held short 14.08M
  • Apr 15, 2025: Shares held short 14.54M
  • Apr 30, 2025: Shares held short 14.62M
  • May 15, 2025: Shares held short 14.36M
  • May 30, 2025: Shares held short 12.94M
  • Jun 13, 2025: Shares held short 13.27M
  • Jun 30, 2025: Shares held short 14.75M
  • Jul 15, 2025: Shares held short 14.70M
  • Jul 31, 2025: Shares held short 12.52M
  • Aug 15, 2025: Shares held short 10.87M
  • Aug 29, 2025: Shares held short 11.80M
  • Sep 15, 2025: Shares held short 13.20M
  • Sep 30, 2025: Shares held short 12.91M
  • Oct 15, 2025: Shares held short 11.48M
  • Oct 31, 2025: Shares held short 13.43M
  • Nov 14, 2025: Shares held short 13.36M
  • Nov 28, 2025: Shares held short 14.32M
  • Dec 15, 2025: Shares held short 14.12M
  • Dec 31, 2025: Shares held short 14.98M
  • Jan 15, 2026: Shares held short 13.96M
  • Jan 30, 2026: Shares held short 13.26M
  • Feb 13, 2026: Shares held short 14.44M
  • Feb 27, 2026: Shares held short 15.11M
  • Mar 13, 2026: Shares held short 14.32M
  • Mar 31, 2026: Shares held short 13.98M
  • Apr 15, 2026: Shares held short 12.74M
  • Apr 30, 2026: Shares held short 12.97M
  • May 15, 2026: Shares held short 12.29M
  • May 29, 2026: Shares held short 11.85M
  • Jun 15, 2026: Shares held short 12.20M
  • Jun 30, 2026: Shares held short 12.87M
  • Jul 15, 2026: Shares held short 12.85M
  • Jul 31, 2026: Shares held short 13.28M
  • Aug 14, 2026: Shares held short 12.04M
  • Aug 31, 2026: Shares held short 12.97M
  • Sep 15, 2026: Shares held short 14.06M
  • Sep 30, 2026: Shares held short 14.03M
  • Oct 15, 2026: Shares held short 13.38M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading51.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 51.7% of the shares in the reported trades were short sales, against 55.4% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
51.7%
The 14 beforeOct 12, 2026 – Oct 29, 2026
55.4%
Change
-3.7 pts
Short sales a dayon average, of 794.9K shares
411.3K
More than atof 3,656 US-listed companies, same days
55%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 61.8%
  • Oct 13, 2026: Short sales 56.2%
  • Oct 14, 2026: Short sales 47.3%
  • Oct 15, 2026: Short sales 43.8%
  • Oct 16, 2026: Short sales 49.9%
  • Oct 19, 2026: Short sales 47.4%
  • Oct 20, 2026: Short sales 63.4%
  • Oct 21, 2026: Short sales 65.4%
  • Oct 22, 2026: Short sales 70.2%
  • Oct 23, 2026: Short sales 42.8%
  • Oct 26, 2026: Short sales 49.2%
  • Oct 27, 2026: Short sales 62%
  • Oct 28, 2026: Short sales 70.2%
  • Oct 29, 2026: Short sales 56.9%
  • Oct 30, 2026: Short sales 60.5%
  • Nov 2, 2026: Short sales 39.8%
  • Nov 3, 2026: Short sales 42.8%
  • Nov 4, 2026: Short sales 51%
  • Nov 5, 2026: Short sales 49.9%
  • Nov 6, 2026: Short sales 61.1%
  • Nov 9, 2026: Short sales 55.8%
  • Nov 10, 2026: Short sales 61.8%
  • Nov 11, 2026: Short sales 49.3%
  • Nov 12, 2026: Short sales 59.1%
  • Nov 13, 2026: Short sales 48.5%
  • Nov 16, 2026: Short sales 53.9%
  • Nov 17, 2026: Short sales 45.1%
  • Nov 18, 2026: Short sales 51.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

244.2K Insiders' shares0.05% Of the company
  • Esteban SantosEVP, Operations
    Directly76.6K
  • Murdo GordonEVP, Global Commercial Ops
    Directly41.9K
  • David M ReeseEVP & Chief Technology Officer
    Directly36.9K
  • Jonathan P GrahamEVP & Gen. Counsel & Secy.
    Directly29.0K
  • Charles M HolleyDirector
    Directly14.5K
  • Derek MillerSVP, Human Resources
    Directly12.5K
  • Omar IshrakDirector
    Directly7,681
  • Nancy A. GrygielSVP & CCO
    Directly7,340
  • Rachna KhoslaSVP, Business Development
    Directly6,404
  • Michael Drake VDirector
    Directly6,030
  • Matthew C. BuschVP, Finance & CAO
    Directly5,080
  • David W GibbsDirector
    Directly278

A lower bound: it counts only the 12 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

Executive pay

From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.

2025 Latest year6 Years on record

$25M

Actually paid: $49M

$8.5M

Actually paid: $15M

$167

Peers: $192

non-GAAP, earnings per share, or EPS

From the proxy statement (DEF 14A) of Apr 7, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A

Share repurchases

How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.

– Repurchases over 4 quarters$6.8B Left in the program
  • Mar 31, 202610-Q
    Amount–
  • Dec 31, 202510-K
    Amount–
  • Sep 30, 202510-Q
    Amount–
  • Jun 30, 202510-Q
    Amount–
  • Mar 31, 202510-Q
    Amount–
  • Sep 30, 202410-Q
    Amount–
  • Jun 30, 202410-Q
    Amount–
  • Mar 31, 202410-Q
    Amount–

From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 6 filing(s) not shown, as the table was not read or did not agree with the cash.

The shareholders' vote on pay

The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.

97.1% For in 20266 Votes on record
  • 2026May 20, 2026
    For
    97.1%
  • 2025May 27, 2025
    For
    94.7%
  • 2024Jun 3, 2024
    For
    93.8%
  • 2023May 22, 2023
    For
    94.0%
  • 2022May 18, 2022
    For
    89.8%
  • 2021May 19, 2021
    For
    93.7%

From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

76 ETFs holding it7.83% The largest weight (IBB)
  • IBBiShares Biotechnology ETF
    Weight in the fund7.83%
  • SCHDSchwab U.S. Dividend Equity ETF
    Weight in the fund4.70%
  • DIADIA
    Weight in the fund4.36%
  • DIVOAmplify CWP Enhanced Dividend Income ETF
    Weight in the fund4.19%
  • IYHiShares U.S. Healthcare ETF
    Weight in the fund3.42%
  • XLVState Street(R) Health Care Select Sector SPDR(R) ETF
    Weight in the fund3.40%
  • VHTVanguard Health Care Index Fund
    Weight in the fund3.21%
  • HDViShares Core High Dividend ETF
    Weight in the fund2.71%
  • IXJiShares Global Healthcare ETF
    Weight in the fund2.54%
  • FTCSFirst Trust Capital Strength ETF
    Weight in the fund2.05%

76 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

3,153 Managers, Q2 2026$162B Value of their positions
  • Q3 2025: Managers 2,830
  • Q4 2025: Managers 3,098
  • Q1 2026: Managers 3,153
  • Q2 2026: Managers 3,153

Institutional investors by quarter

The fund managers holding AMGN, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 3,153 managers held 447M shares, worth $162B. During the quarter 175 opened a position, 175 closed one, 1,230 added and 1,195 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+4.8%
  • Vanguard Capital Management
    In the quarter+0.7%
  • State Street
    In the quarter
  • Capital World Investors
    In the quarter-0.7%
  • Invesco
    In the quarter+2.7%
  • Geode Capital Management
    In the quarter+1.7%
  • Charles Schwab Investment Management
    In the quarter+18%
  • Vanguard Portfolio Management
    In the quarter+1.6%
  • Morgan Stanley
    In the quarter-14%
  • Wells Fargo
    In the quarter+2.1%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

The full analysis

What do Amgen's filings show?

Who buys and sells is one part of Amgen's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about AMGN's shareholders

Didn't find what you were looking for?

Ask us
Have AMGN's insiders bought or sold?

From Aug 7, 2026 to Nov 9, 2026 Amgen's insiders bought 0 and sold $4.1M of shares on the market. 0% of the sales were under set 10b5-1 plans.

Which well-known managers hold AMGN?

5 of the managers we track held the shares on Jun 30, 2026. The largest position was D.E. Shaw's, worth $467M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.